Peptide Sciences USA
Thymosin Alpha-1 10 mg
- Active Substance: Thymosin Alpha-1
- Concentration: 10 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Thymosin
- Molecular Formula: C129H215N33O55
- Molecular Weight: 3108.3 g/mol
- Synonyms: TA1, Zadaxin, Immune Modulator Peptide
Thymosin Alpha-1 (TA1) is a naturally occurring peptide fragment derived from the prothymosin alpha protein, known for its role in modulating immune function. Supplied as a 10 mg injectable vial by Peptide Sciences USA, this research-grade compound is under investigation for its immunoregulatory effects in viral models, autoimmune responses, and general immune system optimization.
Mechanism of Action
Thymosin Alpha-1 binds to Toll-like receptors on immune cells, particularly T lymphocytes and dendritic cells, initiating a cascade that enhances cytokine production and improves T-cell activation. This leads to a more responsive and balanced immune system, especially in immunocompromised or stressed biological models.
TA1 has been shown to increase the activity of CD4+/CD8+ cells, promote natural killer (NK) cell cytotoxicity, and reduce pro-inflammatory cytokines such as TNF-alpha and IL-6. It may also upregulate MHC class I expression, which plays a key role in the recognition of infected or malignant cells. These properties make it a valuable subject of study for chronic viral infections, inflammatory disorders, and immune system recovery.
Key Features & Benefits
- Immune System Enhancement: Supports T-cell and NK-cell function in models of immune suppression or viral infection.
- Anti-Inflammatory Properties: Reduces overactive cytokine responses and inflammation-related damage.
- Research-Backed Peptide: Studied globally in over 30 clinical trials for its safety and efficacy under lab conditions.
- Supports Cellular Defense: May improve host response against intracellular pathogens in immune-related research.
- Made in the USA: Produced by Peptide Sciences to high standards of purity and sterility.
Legal Disclaimer
Disclaimer: Thymosin Alpha-1 is sold strictly for laboratory and preclinical research purposes. It is not approved for human consumption or therapeutic use. This product has not been evaluated by the FDA and must only be handled by qualified professionals in accordance with local laws.
Frequently Asked Questions
Thymosin Alpha-1 (TA1) is a peptide derived from the thymus, studied for its ability to enhance immune responses and modulate inflammation in laboratory settings.
In research models, biological effects may be observed within several days of consistent administration, depending on dosage and subject health parameters.
TA1 is primarily studied for immune system stimulation, viral infection models, immune recovery post-injury, and anti-inflammatory research.
Thymosin Alpha-1 has a favorable safety profile in research and clinical settings, with minimal reported adverse effects when used as directed in preclinical studies.
It is FDA-approved for specific medical indications outside the United States (e.g., hepatitis B/C), but in the U.S., it is limited to investigational or research use only.
Related Products
